Sphingosine 1-phosphate receptor 1signaling in macrophages reduces atherosclerosis in LDL receptor–deficient mice
Sphingosine-1-phosphate receptor
DOI:
10.1172/jci.insight.158127
Publication Date:
2024-11-12T17:00:40Z
AUTHORS (20)
ABSTRACT
Sphingosine 1-phosphate (S1P) is a lysosphingolipid with anti-atherogenic properties, but mechanisms underlying its effects remain unclear. We here investigated atherosclerosis development in cholesterol-rich diet-fed LDL receptor-deficient mice high or low overexpression levels of S1P receptor type 1 (S1P1) macrophages. S1P1-overexpressing macrophages showed increased activity transcription factors PU.1, IRF8, and LXR were skewed towards M2-distinct phenotype characterized by enhanced production IL-10, IL-1RA, IL-5, ATP-binding cassette transporter A1- G1-dependent cholesterol efflux, expression MerTK efferocytosis, reduced apoptosis due to elevated Bcl6 MafB. A similar macrophage was observed administered S1P1-selective agonist KRP203. Mechanistically, the led down-regulation cAMP-dependent protein kinase activation signaling cascade encompassing kinases Akt mTOR complex (mTORC1) as well late endosomal/lysosomal adaptor MAPK activator (Lamtor-1). Atherosclerotic lesions aortic roots brachiocephalic arteries profoundly moderately S1P1 macrophages, respectively. conclude that polarizes an functional countervails mice.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (53)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....